Researchers said Wednesday a lab-manufactured antibody "significantly" reduced HIV blood levels in a small but promising human trial, and caused no harmful side effects. The virus-suppressing action did not appear to last, however, and some patients developed resistance to the agent, said the authors of the research published by Nature. This meant the designer molecule dubbed 3BNC117 may be best used in combination with other drugs, said the team -- while highlighting the promise of a...
Full Story: Yahoo Daily News
